Article
SIRT1-based therapy targets a gene program involved in mitochondrial turnover in a model of retinal neurodegeneration
19 Apr 2025
Abstract excerpt
Neurodegenerative diseases of the eye such as optic neuritis (ON) are hallmarked by retinal ganglion cell (RGC) loss and optic nerve degeneration leading to irreversible blindness. Therapeutic interventions enhancing expression or activity of SIRT1, an NAD + -dependent deacetylase, support, at least in part, survival of RGCs in the face of injury. Herein, we used mice with experimental autoimmune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
